|
Market Closed -
Euronext Paris
11:55:00 2026-10-06 EDT
|
5-day change | 1st Jan Change | ||
| 0.0612 EUR | -9.47% |
|
-15.93% | -53.98% |
| 10-06 | Verdict on October 9 on IntegraGen's future |  |
| 09-11 | ABL Diagnostics Société anonyme proposed to acquire Business operations and assets of IntegraGen SA. | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Bio Diagnostics & Testing
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 500K | - | - | - | - | - |
| 74.31B | |||||
| 56.95B | |||||
| 48.3B | |||||
| 44.51B | - | - | - | - | - |
| 43.8B |
- Stock Market
- Stocks
- ALINT Stock
- Charts IntegraGen
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
